A practical reference on PPARδ: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-12-14. Anything still debated is marked as such rather than presented as settled.
PPARδ is a nuclear receptor that regulates gene expression related to fatty acid oxidation, glucose homeostasis, and mitochondrial function. GW501516 binds to this receptor with high affinity and activates downstream signaling in skeletal muscle and other tissues. Animal studies reported increased endurance and altered fuel preference, but human data remain limited and inconsistent. The precise relationship between receptor activation and observed physiological changes is still an area of active investigation. Researchers have also examined whether the compound affects inflammation or cell proliferation. No approved therapeutic indication exists for cardarine.
In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.
Cardarine is a common name for GW501516, a synthetic compound developed in the 1990s through research collaborations involving GlaxoSmithKline. It belongs to a class of molecules known as peroxisome proliferator-activated receptor delta agonists. Early studies explored its effects on lipid metabolism and energy expenditure in animal models. The compound was never approved as a human medicine, and clinical development was discontinued. In the years since, it has appeared in fitness and bodybuilding communities as a performance-enhancing substance. Regulatory agencies classify it as an unapproved drug.
Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.
Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.
Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.
| Property | Value | Notes |
|---|---|---|
| CAS Registry Number | 317318-70-0 | Unique identifier for the compound. |
| Chemical class | PPARδ agonist | Synthetic ligand for peroxisome proliferator-activated receptor delta. |
| Appearance | White to off-white solid | Typical form of research-grade material. |
| Solubility | Soluble in DMSO and ethanol | Poorly soluble in water. |
| Typical storage | -20°C | Recommended for long-term storage of stock solutions. |
Published human data are sparse and mostly come from early-phase trials. Those studies examined short-term changes in lipids, glucose, and exercise capacity, but they were not large enough to establish efficacy or long-term safety. Some animal experiments reported increased running endurance, yet such findings do not prove a performance benefit in people. Anti-doping laboratories detect GW501516 and its metabolites in urine or blood using liquid chromatography-tandem mass spectrometry. Detection windows depend on dose, sample type, and individual metabolism. The method is sensitive enough to identify trace residues in tested samples.
Laboratory handling focuses on identity, purity, and stability. Reference standards are typically stored cold and dry, protected from light, because solutions can degrade over time. Analytical checks may use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Impurities and related substances can be separated chromatographically and compared with a known standard. Because cardarine is not an approved drug, compendial monographs are absent, and laboratories often rely on in-house methods. Reported purity varies among unregulated products and should not be assumed from a label.
Anti-doping laboratories identify GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the usual matrix, and detection can occur after the parent compound has cleared from blood. The exact detection window depends on dose, formulation, individual metabolism, and assay sensitivity. Because the compound is prohibited at all times, athletes are subject to testing in and out of competition. Analytical methods continue to improve as new metabolites and designer analogs are characterized.
GW501516 acts as a ligand for PPAR delta, a nuclear receptor that regulates transcription of genes involved in fatty acid oxidation and energy use. Activation of this receptor in skeletal muscle shifts metabolism toward fat burning in animal models. The compound does not burn fat directly; it changes gene expression over hours to days. Researchers study it to understand metabolic flexibility and exercise adaptation. Effects observed in rodents are not automatically expected in humans.
Handling and quality assessment of cardarine reference material follow general laboratory practices for poorly characterized compounds. It typically appears as a white to off-white powder and is sparingly soluble in water but soluble in organic solvents such as dimethyl sulfoxide and ethanol. Storage recommendations usually specify a cool, dry, dark place, with long-term storage at low temperature and desiccation. Purity may be checked by high-performance liquid chromatography with ultraviolet detection, while identity is confirmed by mass spectrometry and nuclear magnetic resonance. No pharmacopeial monograph exists, so reported purity and stability depend on the supplier’s methods.
GW501516 acts as a selective agonist at PPARδ, a nuclear receptor that regulates transcription of genes involved in lipid handling and energy metabolism. Activation of PPARδ in preclinical models increases fatty acid oxidation, mitochondrial biogenesis, and exercise endurance in rodents. These effects have made the compound a subject of metabolic research and also a target for sport anti-doping rules. In humans, however, controlled studies are limited, and whether similar endurance or metabolic changes occur at tolerated exposures remains an open question. The receptor’s broad tissue distribution also means downstream effects may vary by organ and condition.
=== Extrapolating in pharmacology === In pharmacology, IVIVE can be used to approximate pharmacokinetics (PK) or pharmacodynamics (PD). Since the timing and intensity of effects on a given target depend on the concentration time course of candidate drug (parent molecule or metabolites) at that target site, in vivo tissue and organ sensitivities can be completely different or even inverse of those observed on cells cultured and exposed in vitro. That indicates that extrapolating effects observed in vitro needs a quantitative model of in vivo PK. Physiologically based PK (PBPK) models are generally accepted to be central to the extrapolations. In the case of early effects or those without intercellular communications, the same cellular exposure concentration is assumed to cause the same effects, both qualitatively and quantitatively, in vitro and in vivo. In these conditions, developing a simple PD model of the dose–response relationship observed in vitro, and transposing it without changes to predict in vivo effects is not enough.
Psilocybin is used as a psychedelic at doses of 5 to 40 mg orally. Low doses are 5 to 10 mg, an intermediate or "good effect" dose is 20 mg, and high or ego-dissolution doses are 30 to 40 mg. Psilocybin's effects can be subjectively perceived at a dose as low as 3 mg per 70 kg body weight. Microdosing involves the use of subthreshold psilocybin doses of less than 2.5 mg. When psilocybin is used in the form of psilocybin-containing mushrooms, microdoses are 0.1 g to 0.3 g and psychedelic doses are 1.0 g to 3.5–5.0 g in the case of dried mushrooms. The preceding 1.0 to 5.0 g range corresponds to psilocybin doses of about 10 to 50 mg. Psilocybin-containing mushrooms vary in their psilocybin and psilocin content, but are typically around 1% of the dried weight of the mushrooms (in terms of total or combined psilocybin and psilocin content). Psilocin is about 1.4 times as potent as psilocybin because of the two compounds' difference in molecular weight. "Lemon tek" or "lemon tekking" is a method sometimes used by recreational psilocybin users. It involves soaking psilocybin-containing mushrooms in citric acid-containing lemon juice to supposedly convert their psilocybin content into psilocin before administration. This is claimed to hasten their onset, cause a sharper and more intense peak, and shorten their duration.
Center for Strategic and International Studies (CSIS) specialist Clayton Seigle said oil companies sought stability in Venezuela above all else, adding that the outlook for US interests in the country remained uncertain. Another CSIS expert, Christopher Hernandez-Roy, said Trump's reluctance to engage in full regime change was driven by fear of chaos, noting that, aside from Maduro's removal, the current regime remained unchanged. American political analyst David Rothkopf described President Trump's conduct as the "Putinization of US foreign policy". Analysts Ryan C. Berg and Alexander B. Gray stated that the action showed a robust commitment to Trump's 2025 National Security Strategy (NSS) and a desire to increase preeminence in the Western Hemisphere, in turn signaling a "global reestablishment of deterrence" to countries such as China, alluding to the latter's investments in Venezuela. Atlantic Council Counterterrorism Project head Alex Plitsas urged an orderly transition, warning that instability in Venezuela could lead to political fragmentation and criminal violence involving colectivo gangs; Berg elaborated that any systemic change would likely be lengthy, while reinforcing the Trump administration's "America First" agenda. Indian political analyst Brahma Chellaney argued that while the legal framing (drug trafficking charges) resembles the 1989 invasion of Panama and the seizure of Manuel Noriega, the actual methodology and strategic narrative align more closely with the 2003 invasion of Iraq.
HVEC's first product line targeted cancer treatment, an application that demonstrated the practical value of controlled particle acceleration for medicine. Between 1948 and 1969, the company manufactured compact 2-megavolt electron accelerators designed for hospital radiotherapy departments. These 8-foot-long generators could be operated by technicians and nurses, making radiation therapy accessible beyond major research hospitals. During their production run, 35 U.S. hospitals and eight hospitals abroad installed the machines for cancer treatment. The generators addressed significant limitations in available cancer treatments. Traditional radiotherapy relied on radium sources, which were expensive, scarce, and produced uncontrolled radiation that damaged healthy tissue surrounding tumors. Low-voltage (0.25 MV) x-ray devices were available, but lacked sufficient penetration to treat deep tumors and caused violent skin reactions. HVEC's 1- and 2-MV Van de Graaff accelerators generated artificial X-rays that could be precisely aimed and modulated, allowing physicians to target deep-seated tumors while minimizing exposure to surrounding organs. The beam energy could be adjusted to match tumor depth, and therapy could be spread across multiple sessions to reduce side effects. HVEC also supported medical research.
Southern African Association of Freight Forwarders (SAAFF) Chartered Institute of Logistics and Transport (CILT) International Federation of Freight Forwarders Associations (IFFFA) The Fuels Industry Association of South Africa (FIASA) Road Freight Association (RFA) SAPICS South African Express Parcel Association (SAEPA) South African Association of Ship Operators and Agents (SAASOA) African Rail Industry Association (ARIA) Commercial Aviation Association of Southern Africa (CAASA) Fresh Produce Exporters' Forum (FPEF)
Sources: en.wikipedia.org
The first paramilitary groups were organized following recommendations made by U.S. military counterinsurgency advisers, who were sent to Colombia during the Cold War to combat leftist political activists and armed guerrilla groups. One multinational corporation has also been directly tied to paramilitary death squads. Chiquita Brands International was fined $25 million as part of a settlement with the United States Justice Department for having ties to paramilitary groups. In 2016, Judge Kenneth Marra of the Southern District of Florida ruled in favor of allowing Colombians to sue former Chiquita Brand International executives for the company's funding of the outlawed right-wing paramilitary organization that murdered their family members. He stated in his decision that "'profits took priority over basic human welfare' in the banana company executives' decision to finance the illegal death squads, despite knowing that this would advance the paramilitaries' murderous campaign." In December 2013, The Washington Post revealed a covert CIA program, started in the early 2000s, which provided the Colombian government with intelligence and GPS guidance systems for smart bombs. As of August 2004, the US had spent $3 billion in Colombia, more than 75% of it on military aid. Before the Iraq War, Colombia was the third largest recipient of US aid, only after Egypt and Israel, and the U.S. has 400 military personnel and 400 civilian contractors in Colombia.[3][4] Currently, however, Colombia is not a top recipient of U.S.
=== Lipedema stages === Lipedema is classified by stage: Stage 1: Normal skin surface with enlarged hypodermis (lipedema fat). Stage 2: Uneven skin with indentations in fat and larger hypodermal masses (lipomas). Stage 3: Bulky extrusions of skin and fat cause large deformations, especially on the thighs and around the knees. These large extrusions of tissue drastically inhibit mobility.
=== Pharmacodynamics === Nicotinic acid activates the HCA2 receptor, which has effects in addition to lowering serum cholesterol and triglyceride concentrations: antioxidative, anti-inflammatory, antithrombotic, improved endothelial function and plaque stability, all of which counter development and progression of atherosclerosis. Nicotinic acid inhibits cytochrome P450 enzymes CYP2E1, CYP2D6 and CYP3A4. Niacin produces a rise in serum unconjugated bilirubin in normal individuals and in those with Gilbert's Syndrome. However, in the Gilbert's Syndrome, the rise in bilirubin is higher and clearance is delayed longer than in normal people. One test used to aid in diagnosing Gilbert's Syndrome involves intravenous administration of nicotinic acid (niacin) in a dose of 50 mg over a period of 30 seconds.
Agarose is a polysaccharide, generally extracted from certain red algae. It is a linear polymer made up of the repeating unit of agarobiose, which is a disaccharide made up of D-galactose and 3,6-anhydro-L-galactopyranose. Agarose is one of the two principal components of agar, and is purified from agar by removing agar's other component, agaropectin. Agarose is frequently used in molecular biology for the separation of large molecules, especially DNA, by electrophoresis. Slabs of agarose gels (usually 0.7 - 2%) for electrophoresis are readily prepared by pouring the warm, liquid solution into a mold. A variety of different agaroses of varying molecular weights and properties are commercially available for this purpose. Agarose may be formed into beads and used in a number of chromatographic methods for protein purification. It can also be used instead of agar as a solid medium for culturing cells and organisms.
Sources: en.wikipedia.org
The NHS Grampian health board announcing it is to divert ambulance patients to hospitals outside its area because of "critical" pressure on its largest hospital. 29 November – Finlay MacDonald, who carried out a series of shootings on the Isle of Skye and the Scottish mainland, which included the fatal shooting of his brother-in-law, is sentenced to life imprisonment with a minimum term of 28 years. GP leaders in Scotland vote in favour of a motion to ballot workers on industrial action over pay, following what they describe as "years of disinvestment in general practice". 30 November – The Proclaimers perform at a memorial service for former first minister Alex Salmond, held at Edinburgh's St Giles' Cathedral.
A body fat meter is a tool used to measure the body fat to weight ratio in the human body. Different meters use various methods to determine the ratio. They tend to under-read body fat percentage. In contrast with clinical tools like DXA and underwater weighing, one relatively inexpensive type of body fat meter uses the principle of bioelectrical impedance analysis (BIA) in order to determine an individual's body fat percentage. To achieve this, the meter passes a small, harmless, electric current through the body and measures the resistance, then uses information on the person's weight, height, age, and sex to calculate an approximate value for the person's body fat percentage. The calculation measures the total volume of water in the body (lean tissue and muscle contain a higher percentage of water than fat), and estimates the percentage of fat based on this information. The result can fluctuate several percentage points depending on what has been eaten and how much water has been drunk before the analysis. This method is quick and readily accessible, but imprecise. Alternative methods are: skin fold methods using calipers, underwater weighing, whole body air displacement plethysmography (ADP) and DXA.
== Interpretation == In the United States and in most European countries creatinine is usually reported in mg/dL, whereas in Canada, Australia, and a few European countries, such as the UK, μmol/L is the usual unit. One mg/dL of creatinine equals 88.4 μmol/L. The typical human reference ranges for serum creatinine are 0.5 mg/dL to 1.0 mg/dL (about 45 μmol/L to 90 μmol/L) for women and 0.7 mg/dL to 1.2 mg/dL (60 μmol/L to 110 μmol/L) for men. The significance of a single creatinine value must be interpreted in light of the patient's muscle mass. Patients with greater muscle mass have higher creatinine concentrations.
=== Broader Arab response === In the broader Arab world, the declaration was seen as a betrayal of the British wartime understandings with the Arabs. The Sharif of Mecca and other Arab leaders considered the declaration a violation of a previous commitment made in the McMahon–Hussein correspondence in exchange for launching the Arab Revolt. Following the publication of the declaration in an Egyptian newspaper, Al Muqattam, the British dispatched Commander David George Hogarth to see Hussein in January 1918 bearing the message that the "political and economic freedom" of the Palestinian population was not in question. Hogarth reported that Hussein "would not accept an independent Jewish State in Palestine, nor was I instructed to warn him that such a state was contemplated by Great Britain". Hussein had also learned of the Sykes–Picot Agreement when it was leaked by the new Soviet government in December 1917, but was satisfied by two disingenuous messages from Sir Reginald Wingate, who had replaced McMahon as High Commissioner of Egypt, assuring him that the British commitments to the Arabs were still valid and that the Sykes–Picot Agreement was not a formal treaty.
== External links == Sulfur at The Periodic Table of Videos (University of Nottingham) Atomic Data for Sulfur, NIST Physical Measurement Laboratory Sulfur phase diagram Archived 23 February 2010 at the Wayback Machine, Introduction to Chemistry for Ages 13–17 Crystalline, liquid and polymerization of sulfur on Vulcano Island, Italy Sulfur and its use as a pesticide The Sulphur Institute Nutrient Stewardship and The Sulphur Institute
Sources: en.wikipedia.org
Cardarine is a common name for GW501516, a synthetic PPARδ agonist developed for research. It has not been approved as a medication in any country. It is classified as an unapproved drug and a prohibited substance in sport.
No. Cardarine is not an anabolic steroid; it belongs to a different chemical class that targets PPARδ. Steroids act primarily through androgen receptors, while cardarine acts through a nuclear receptor involved in metabolism.
Some rodent studies reported increased endurance and changes in fat metabolism after cardarine exposure. Long-term studies in animals also raised concerns about cancer in certain tissues. Human trial data are limited, so these findings cannot be directly translated to people.
No. Major drug regulators have not approved GW501516 for treating any medical condition. Products sold as cardarine are typically unapproved research chemicals or supplements, so their contents and safety are not assured.